entecavir has been researched along with Epstein-Barr-Virus-Infections* in 1 studies
1 other study(ies) available for entecavir and Epstein-Barr-Virus-Infections
| Article | Year |
|---|---|
Infusion of leukocytes from HLA haplo-identical familial donors as an adjuvant in the HLH-2004 protocol to treat the virus-associated adult hemophagocytic lymphohistiocytosis: a retrospective study of 26 patients.
Adult hemophagocytic lymphohistiocytosis (HLH) is a fatal disease with poor survival and a limited role of drug therapies. To help to recognize virus and enhance survival, we infused leukocytes derived from human leukocyte antigen (HLA) haplo-identical familial donors to patients. We retrospectively investigated 26 adult virus-associated hemophagocytic syndrome (VAHS) patients' medical records from 2006-2017. Eleven of the 26 patients accepted relatives' derived leukocytes infusions in addition to drug therapies recommended in the HLH-2004 protocol. The leukocyte doses ranged from 0.75 to 3.30×10 Topics: Adjuvants, Immunologic; Adolescent; Adult; Antiviral Agents; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Family; Female; Ganciclovir; Guanine; Haplotypes; Herpesvirus 4, Human; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukocyte Transfusion; Leukocytes; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Retrospective Studies; Survival Analysis; Tissue Donors; Treatment Outcome; Viral Load | 2018 |